Table 12. Microfilaridermia.
| Pre-treatment | 6 months | |||
|---|---|---|---|---|
| Mf-positive | Mf-negative | Mf-positive | Mf-negative | |
| DOX 4w | 16 (66.7%) | 8 (33.3%) | 16 (66.7%) | 8 (33.3%) |
| DOX 3w + ALB 3d | 11 (61.1%) | 7 (38.9%) | 13 (72.2%) | 5 (27.8%) |
| MIN 3w | 13 (61.9%) | 8 (38.1%) | 12 (57.1%) | 9 (42.9%) |
| DOX 3w | 12 (63.2%) | 7 (36.8%) | 11 (57.9%) | 8 (42.1%) |
| ALB 3d | 13 (65.0%) | 7 (35.0%) | 12 (60.0%) | 8 (40.0%) |